Participants on the highest dose lost up to 24.2% of body weight over 48 weeks
On the cost front, while insurance coverage for GLP1 receptor agonists has increased as of late, many payers still do not cover these medications for obesity alone (i.e., without the presence of other approved indications)
This is often triggered by cold exposure or after nursing and can sometimes be mistaken for thrush
Data availability All the relevant data that cannot compromise patient confidentiality, and that support the findings of this study, are within the manuscript and its supporting information files
Wilkie M, Pontoriero G, Macrio F, Yaqoob M, Bouman K, Braun J, von Albertini B, Brink H, Maduell F, Graf H, Frazo JM, Bos WJ, Torregrosa V, Saha H, Reichel H, Zani VJ, Carter D, Messa P